Myocardial Remodeling in Hypertension: Toward a New View of Hypertensive Heart Disease

被引：139

作者：

Gonzalez, Arantxa ^{[1
,2
,3
]}

Ravassa, Susana ^{[1
,2
,3
]}

Lopez, Begona ^{[1
,2
,3
]}

Moreno, Maria U. ^{[1
,2
,3
]}

Beaumont, Javier ^{[1
,2
,3
]}

San Jose, Gorka ^{[1
,2
,3
]}

Querejeta, Ramon ^{[4
]}

Bayes-Genis, Antoni ^{[3
,5
,6
,7
]}

Diez, Javier ^{[1
,2
,3
,8
,9
]}

机构：

[1] Univ Navarra, Ctr Appl Med Res, Program Cardiovasc Dis, Ave Pio 12,55, Pamplona 31008, Spain

[2] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain

[3] Carlos III Inst Hlth, CIBERCV, Madrid, Spain

[4] Univ Basque Country, Donostia Univ Hosp, Div Cardiol, San Sebastian, Spain

[5] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain

[6] Hosp Badalona Germans Trias & Pujol, Cardiol Serv, Badalona, Spain

[7] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain

[8] Univ Navarra, Univ Navarra Clin, Dept Cardiol & Cardiac Surg, Pamplona, Spain

[9] Univ Navarra, Univ Navarra Clin, Dept Nephrol, Pamplona, Spain

来源：

HYPERTENSION | 2018年 / 72卷 / 03期

关键词：

LEFT-VENTRICULAR HYPERTROPHY; REGULATORY T-CELLS; PRESERVED EJECTION FRACTION; PATHOLOGICAL CARDIAC-HYPERTROPHY; CORONARY FLOW RESERVE; C-REACTIVE PROTEIN; DIASTOLIC DYSFUNCTION; ARTERIAL-HYPERTENSION; GENE-EXPRESSION; BLOOD-PRESSURE;

D O I：

10.1161/HYPERTENSIONAHA.118.11125

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

[No abstract available]

引用

页码：549 / 558

页数：10

共 104 条

[81] Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome [J].

Ravassa, Susana ;

Lopez, Begona ;

Querejeta, Ramon ;

Echegaray, Kattalin ;

San Jose, Gorka ;

Moreno, Maria U. ;

Beaumont, Francisco J. ;

Gonzalez, Arantxa ;

Diez, Javier .

JOURNAL OF HYPERTENSION, 2017, 35 (04) :853-861

[82] Arrhythmogenic Implications of Fibroblast-Myocyte Interactions [J].

Rohr, Stephan .

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (02) :442-452

[83]

Scheuer J, 1999, AM J CARDIOL, V83, p70H

[84] Is Inhibition of Hypertrophy a Good Therapeutic Strategy in Ventricular Pressure Overload? [J].

Schiattarella, Gabriele G. ;

Hill, Joseph A. .

CIRCULATION, 2015, 131 (16) :1435-1447

[85] STRUCTURAL AND FUNCTIONAL ALTERATIONS OF THE INTRAMYOCARDIAL CORONARY ARTERIOLES IN PATIENTS WITH ARTERIAL-HYPERTENSION [J].

SCHWARTZKOPFF, B ;

MOTZ, W ;

FRENZEL, H ;

VOGT, M ;

KNAUER, S ;

STRAUER, BE .

CIRCULATION, 1993, 88 (03) :993-1003

[86] Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure CHS (Cardiovascular Health Study) [J].

Seliger, Stephen L. ;

de Lemos, James ;

Neeland, Ian J. ;

Christenson, Robert ;

Gottdiener, John ;

Drazner, Mark H. ;

Berry, Jarett ;

Sorkin, John ;

deFilippi, Christopher .

JACC-HEART FAILURE, 2015, 3 (06) :445-455

[87] Hypertension, left ventricular hypertrophy, and sudden cardiac death [J].

Shenasa, Mohammad ;

Shenasa, Hossein .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 237 :60-63

[88] Physiological and pathological cardiac hypertrophy [J].

Shimizu, Ippei ;

Minamino, Tohru .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 97 :245-262

[89]

Shinde AV, 2017, CURR PATHOBIOL REP, V5, P145, DOI 10.1007/s40139-017-0132-z

[90] Cellular mechanisms of cardiac hypertrophy [J].

Sugden, PH ;

Clerk, A .

JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (11) :725-746

← 2 3 4 5 6 7 8 9 10 11 →